L

01513

Livzon Pharmaceutical Group

26.65

0.50+1.91%
Opening11:33 11/01 HKT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE25.850/26.150
TODAY RANGE25.850-26.800
VOL260.00K
MARKET CAP24.70B
52 WEEK RANGE22.350-34.000
AVG VOL (3M)636.83K
% TURNOVER0.03%
TURNOVER6.91M
P/E (TTM)11.003
% RANGE3.63%
EPS(TTM)2.422
P/E(FORWARD)10.954
P/B1.573
BVPS16.937
DIVIDEND1.482
P/S1.558
BETA--
DIV YIELD5.56%
FREE FLOAT MKT CAP8.18B
SHARES OUTSTANDING927.00M
NEXT EARNINGS--
FREE FLOAT307.05M
LOT SIZE100
EX-DIV DATE07/08/2024
Feeds
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

L

Livzon Pharmaceutical Group

01513

+1.91%
26.650

A

Amgen

04332

--

C

China Conch Venture Holdings

00586

+0.42%
7.250

W

Wuxi Apptec

02359

+0.39%
51.900

A

Asymchem Laboratories (Tianjin)

06821

+0.97%
57.000

S

Sinopharm Group

01099

+0.72%
19.480

G

Guangzhou Baiyunshan Pharmaceutical Holdings

00874

+0.44%
18.360

S

Shanghai Pharmaceuticals Holding

02607

+1.83%
12.220

S

Shanghai Fosun Pharmaceutical (Group)

02196

+0.68%
14.900

C

China Medical System Holdings

00867

+1.16%
7.880

S

SciClone Pharmaceuticals (Holdings)

06600

0.00%
18.720

W

Wuxi Biologics (Cayman)

02269

+0.73%
16.460

C

China Isotope & Radiation

01763

+0.71%
11.360

C

China Shineway Pharmaceutical Group

02877

+1.41%
9.330

T

The United Laboratories International Holdings

03933

-0.19%
10.540

C

Consun Pharmaceutical Group

01681

+2.90%
8.510

3

3SBio

01530

+0.69%
5.870

S

Shandong Xinhua Pharmaceutical

00719

+0.34%
5.920

B

Beijing Tong Ren Tang Chinese Medicine

03613

+1.60%
8.260

C

China Resources Pharmaceutical Group

03320

+0.73%
5.540

C

CSPC Pharmaceutical Group

01093

-8.87%
5.240
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.